Albemarle Cuts 2026 Capital Spending Guidance to $300 Million-$350 Million
Albemarle cut its 2026 capital spending guidance to $300 million-$350 million.
Related stories
RenovoRx raises 2026 revenue outlook to $3.75 million-$4.25 million
M impact | EARNINGS | Nov 11, 2026, 07:29 PM UTC
Allianz Reports Nine-Month Result of €14.1 Billion, Raises 2026 Outlook
M impact | EARNINGS | Nov 11, 2026, 06:50 PM UTC
Allianz upgrades 2026 profit outlook
M impact | EARNINGS | Nov 11, 2026, 06:50 PM UTC
Carlsmed Shares Jump 23% After Higher Third-Quarter Revenue, Raised Guidance
Carlsmed reported third-quarter revenue above the year-earlier level and raised its 2026 revenue guidance. Shares traded 23% higher at $18.13, after reaching a session 52-week high
M impact | EARNINGS | Nov 11, 2026, 06:45 PM UTC
Allianz Sees FY Oper Profit Between EUR16.4B - EUR18.6B, Saw EUR16.4B - EUR18.4B
9M Operating Profit EUR14.1B Vs EUR13.1B (Y/Y)
L impact | EARNINGS | Nov 11, 2026, 06:45 PM UTC
Allianz Raises 2026 Operating Profit Guidance Ceiling to About €18.6 Billion
M impact | EARNINGS | Nov 11, 2026, 06:29 PM UTC